In addition to these tumor characteristics, biomarkers for preserved liver function and the liver damage status of the HCC patients, such as the Child-Pugh stage; the α-fetoprotein (AFP), bilirubin, and albumin levels; and ECOG status are also associated with the prognosis of HCC patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.